$JUUL

Altria has been under scrutiny for its business practices, particularly in relation to smoking and vaping products. Recently, Wall Street has started to acknowledge the value of Altria's strong dividend yield and strategic partnerships, particularly with Juul Labs. Analysts are adjusting their forecasts to reflect improved projections amid regulatory clarity in the market. With a recovering sentiment, investors may shift back towards Altria as it presents a buying opportunity. Overall, the stock appears poised for a rebound as confidence in the tobacco sector grows.